Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NovaScan LLC

Latest From NovaScan LLC

The Evolving World Of Breast Cancer Management

The device industry is playing a pivotal role in the evolution toward a more personalized approach to breast cancer management, with ongoing advances in minimally invasive treatment systems, tumor characterization and breast imaging technologies adding to the momentum. In the years ahead, as the breast cancer toolbox expands, the watchword will be “choice,” with physicians and patients offered more treatment options, targeted to their specific needs and desires, than ever before.

Medical Device Surgical Procedures

NovaScan LLC

The rates of reoperation after breast conservation therapy vary between 25 and 49%, due to the presence of tumor cells remaining in the surrounding tissue after the tumor is removed. NovaScan hopes to reduce the need for these reoperations. Its FastPath residual cancer probe is designed to identify normal, benign and malignant tissue types remaining inside the surgical cavity and in excised tissue in real time during surgery.

Medical Device

Breast Cancer Diagnostics: Start-Ups Look To Fill Gaps In The Patient Care Continuum

Mammography is a mature and successful breast cancer diagnostic technology, but it has many drawbacks, including high false-negative and false-positive rates, the use of ionizing radiation, and ineffectiveness in dense or scarred breast tissue. Emerging companies aim to improve on this gold standard as well as streamline radiological workflow and predict disease aggressiveness and recurrence. START-UP profiles four such companies in this issue: Delphinus Medical Technologies, Ibris, NovaScan and Real Time Tomography.

Medical Device

Start-Up Previews

This Month's Profile Group: Breast Cancer Diagnostics: Start-Ups Look To Fill Gaps In The Patient Care Continuum, features profiles of Delphinus Medical Technologies, Ibris, NovaScan and Real Time Tomography. Plus these Start-Ups Across Health Care: NewGen Therapeutics, Ozics, PlantForm and PsiOxus.

See All

Company Information

  • Industry
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • NovaScan Systems LLC
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • NovaScan LLC
  • Senior Management
  • William Gregory, PhD, CSO
  • Contact Info
  • NovaScan LLC
    Phone: (414) 839-3279
    Aurora Sinai Med. Ctr., 950 N. 12th St.
    Ste. 602/604
    Milwaukee, WI 53233